Chief Business Development Off of Adaptive Biotechnologies Corp (NASDAQ:ADPT), Benzeno Sharon, sells 416 shares worth $20,326
According to Adaptive Biotechnologies Corp's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 23 06:05 AM, company Chief Business Development Off, Benzeno Sharon disclosed selling 416 shares at a cost of $48.86. At the time of this transaction (Nov 19), this trade was worth $20,326 in total. As of Nov 19, Benzeno Sharon now owns 0 shares in total worth about $0.0.
For the last few recent trades made by Adaptive Biotechnologies Corp (NASDAQ:ADPT) Chief Business Development Off, Benzeno Sharon, we have the following information:
- SEC Form 4 filing: Nov 02: Sold 6,772 shares at the rate of $45.58 per share. Total worth of this trade was $308,642. Total number of shares owned as of Nov 02 were 0
- SEC Form 4 filing: Oct 19: Sold 417 shares at the rate of $51.25 per share. Total worth of this trade was $21,371. Total number of shares owned as of Oct 19 were 0
- SEC Form 4 filing: Oct 01: Sold 6,771 shares at the rate of $48.57 per share. Total worth of this trade was $328,837. Total number of shares owned as of Oct 01 were 0
Posted by
George Daniels
on Monday November 23 2020, 10:07 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
